Examination of Glutamate and mGluR5 in Psychiatric Disorders
Volunteers
Health Professionals
What is the purpose of this trial?
This research study is designed to look at the involvement of the glutamate system in depression. Each subject will undergo a screening appointment to determine study eligibility. Thereafter, the study will take 2 or 3 visits depending on schedule availability and will consist of one MRI scan, and PET scan. Subjects will also participate in cognitive testing. Depending on camera time, staff availability and subject schedule, total study participation may last 1-2 months.
- Trial withYale University School of Medicine and National Institute of Mental Health (NIMH)
- Ages18 years - 65 years
- GenderBoth
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Ansel Hillmer, PhD
- Chadi Abdallah, MD
- David Matuskey, MD
- Deepak Cyril Dsouza, MBBS, MD
- Gerard Sanacora, PhD, MD
- Graeme Mason, PhD
- Hilary Blumberg, MD
- John Krystal, MD
- Kelly Cosgrove, PhD
- Michael Bloch, MD, MS
- Ming-Kai Chen, MD, PhD
- Neha Pashankar
- Richard Carson, PhD
- Sophie E Holmes, PhD
- Stephen Baldassarri, MD, MHS
- Tore Eid, MD, PhD
- Last Updated10/17/2024
- Study HIC#1101007933